NCT01331187 Influence of Routinely Adding Ultrasound Screening in Medical Department Status COMPLETED Phase NA
NCT01235936 Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia Status COMPLETED Phase PHASE2
NCT01228279 Sympathetic Activity in Patients With End-stage Renal Disease on Peritoneal Dialysis Status COMPLETED Phase PHASE4
NCT01150201 Aliskiren Combined With Losartan in Proteinuric, Non-diabetic Chronic Kidney Disease Status COMPLETED Phase PHASE4
NCT01143532 Role of Donor Genetics and Recipient Genetics in Kidney Transplant Outcomes Status COMPLETED Phase N/A
NCT01111266 Determination of in Vivo Ultrafiltration Coefficient (KUF) in Patients With Chronic Kidney Disease (CKD) Status COMPLETED Phase NA
NCT01087749 Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01081210 Screening of Patients Admitted to a Local Hospital With Pocket-sized Ultrasound Status COMPLETED Phase N/A
NCT01068080 Involvement of FFA Metabolism and Insulin Resistance in Cardiac Death Status COMPLETED Phase N/A
NCT01052779 A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease Status COMPLETED Phase PHASE2
NCT01047397 Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia Status COMPLETED Phase PHASE2
NCT00975702 Remote Ischemic Preconditioning In Abdominal Organ Transplantation Status COMPLETED Phase PHASE3
NCT00975000 Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Status COMPLETED Phase PHASE3
NCT00974636 Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial Status COMPLETED Phase NA
NCT00950573 Arterial Calcifications in Nocturnal Hemodialysis and Renal Transplantation Versus Conventional Dialysis Status COMPLETED Phase N/A
NCT00935831 Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment Status COMPLETED Phase PHASE1
NCT00854620 Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer Status COMPLETED Phase PHASE2
NCT00843349 Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD) Status COMPLETED Phase NA